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Abstract: Plasma fibrinogen levels and factor VIII:c activity were increased after intramuscular 
injections of turpentine in ten rabbits, which caused an acute inflammatory reaction, while plasma protein C 
activity (an anticoagulant mechanism) was slightly yet significantly decreased. The inflammatory reaction also 
caused an increase of plasma antithrombin III activity. These changes should be interpretated in the more 
complex context of hemostatic perturbations caused by the acute phase reaction and may be involved in the 
intravascular deposition of fibrin.  
 Clinical and experimental studies have  suggested that inflammation leads to complex hemostatic 
disturbances, consisting of the increase of procoagulant variables such as fibrinogen, clotting factor VIII, von 
Willebrand factor, but also of the stimulation of antithrombin III, an anticoagulant mechanism. On the other 
hand, plasma  protein C, another potent anticoagulant mechanism decreases during the acute phase reaction.  
 
MATERIAL AND METHODS 
 
 The experiment was performed on 10 rabbits weighing 2 kg. Blood was harvested 
from the ear vein and 1,8 ml blood were immediately mixed with 0,2 ml of 3,8% sodium 
citrate. Platelet poor plasma (PPP) samples were obtained after a 20 min centrifugation of the 
citrated blood at 3000 rpm. Plasma samples were stored at – 20 o C in small capped plastic 
tubes. The frozen plasma samples were thawed at 37o C, 30 min prior the assay.  
 The rabbits were then submitted to an intramusculary injection  with 0,75 ml 
turpentine into each thigh (total 1,5 ml turpentine). 48 hours after the injection blood was 
harvested again, in the conditions previously mentioned.  
 Plasma fibrinogen was measured according to the method described by  Astrup (1). 
Protein C activity was measured using an end-point chromogenic method (Berichrom Protein 
C Behring). Factor VIII:c was measured using a coagulometric method consisting in the 
correction by the rabbit plasma samples of a factor VIII:c deficient plasma (Diagnostica 
Stago). Antithrombin III activity was measured using a kinetic chromogenic procedure 
(Berichrom Antithrombin III, Behring). The results were expressed as percentage of  the 
activity of  standard human plasma  (Boehringer Mannheim). 
 Significance of changes of  the investigated parameters was evaluated by paired 




 The acute inflammatory reaction induced by turpentine led to an important increase of 
plasma fibrinogen, and factor VIII:c, while antithrombin III displayed a less obvious, yet 
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statistically significant elevation . Protein C plasma levels showed a slight yet significant 
decrease (Table 1). Comparing to humans, plasma protein C levels are lower and plasma 
clotting factor VIII:c are higher in rabbits, even before the experimental inflammatory 
reaction.  
 
Table 1 Effect of intramusculary injection of turpentine on plasma fibrinogen level,as on factor VIII:c, protein C 
and  antithrombin III activities. Figures representing values ± SEM were obtained in 10 rabbits before (I) and 48 
hours after turpentine injection (II) 
 
 Fibrinogen  
(mg /dl) 
Antithrombin III 
(% of standard 
human plasma) 
Factor VIII:c 
(% of human 
standard plasma) 
Plasma protein C 
(% of standard 
human plasma) 
I 303 ± 26 80 ± 10,81 233 ± 19,3 52.7 ± 3,63 
II 650 ± 28 123 ±  6,56 528 ± 42 45,8 ± 2,8 
Statistical significance by 
paired difference analysis 




 Data in the literature and the authors’ own previous observations show that there is a 
relationship between  the acute phase reaction and modification of the hemostatic variables, 
which may create the conditions for a thrombotic event.  Trauma, sepsis or surgical  
procedures may lead to thrombosis, especially in subjects with other risk factors (2), and the 
acute phase reaction accompanying the above mentioned conditions may represent a 
triggering factor. Mechanisms linking inflammation to thrombosis are well documented, yet 
not fully elucidated. One may presume that the endothelial injury induced by the 
inflammatory reaction result in a down-regulation of some of the anticoagulant  mechanisms, 
while the procoagulant factors  and fibrinolysis inhibitors are up-regulated.  
 The presently reported changes of plasma fibrinogen and factor VIII:c levels  are 
confirming previous observations (12, 14).These experimental data obtained in vivo are 
similar to those obtained by Hoffman et al (8) in rat hepatocyte cultures stimulated with 
macrophage stimulated cytokines. 
 Plasma fibrinogen is known as an acute phase reactant; its level is increased in 
inflammation, malignancy and pregnancy. High levels of plasma fibrinogen are associated 
with an important risk for coronary heart disease and stroke. (7). 
  Concerning the behaviour of the  anticoagulant mechanisms during the acute phase 
reaction, both up- regulation and down - regulation processes are reported. Proinflammatory 
cytokines induce an increased synthesis of antithrombin III, while impairing the hepatic 
synthesis protein C. The plasma level of antithrombin III was found to increase in several  
experimental and clinical conditions accompanied by an acute phase reaction (4,13). The 
actual plasma level of antithrombin III activity during an inflammatory reaction is the result of 
an increased synthesis and an enhanced consumption.  
 The presently reported decrease of plasma protein C suggests that this antithrombotic 
mechanism is down – regulated by inflammation (5). One may wonder what could be the 
pathophysiological relevance of this change. Protein C system may become down regulated 
by several other mechanisms associated with the acute phase reaction. Protein S, a cofactor of 
protein C is also decreased during the acute phase reaction (3). Furthermore, the increase in 
plasma level of c4b binding protein (an acute phase reactant that also binds protein S) results 
in a decrease of free protein S, and subsequently in a reduced cofactor activity for activated 
protein C.  
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 The thrombin - thrombomodulin complex exerts an anticoagulant function through 
protein C system, and an antifibrinolytic effect by activating TAFI (10, 11). It seems that local 
concentration of thrombomodulin influences the balance between these two effects:  at low 
concentration of thrombomodulin TAFI activation is predominant, while at higher 
concentrations, protein C activation is predominant, resulting in decrease of thrombin 
generation and subsequent TAFI activation. 
 Recent studies showed that activated protein C has a variety of antiinflammatory 
activities. It suppresses inflammatory cytokine elevation in animal models of severe sepsis, 
inhibits leukocyte adhesion, decreases leukocyte chemotaxis, reduces endothelial cell 
apoptosis, helps maintain endothelial cell barrier function through activation of the 
sphingosine-1 phosphate receptor, and minimizes the decrease in blood pressure associated 
with severe sepsis. Most of these functions are dependent on binding to endothelial protein C 
receptor (EPCR). It seems that this pathway is critical to both regulation of the blood 
coagulation process, and control of the innate inflammatory response and some of its 
associated downstream pathologies.(6,9). 
 An overall view of these inflammation-related mechanisms suggests that the enhanced 
procoagulant activities, represented by the increase of fibrinogen and factor VIII:c and the 
impaired function of the protein C system are favourable to the local deposition of fibrin, 
while the increase of the antithrombin III activity might represent an attempt to prevent or to 
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